Report overview
A measurable DNA and/or RNA characteristic is an indicator of normal biologic processes, pathogenic processes, and/or response to a therapeutic or other interventions. A genomic biomarker can be used for measuring the expression, function, and regulation of a gene. These biomarkers have characteristics of one or more deoxyribonucleic acid (DNA) and/or ribonucleic acid (RNA).
This report aims to provide a comprehensive presentation of the global market for Genomics Biomarkers, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Genomics Biomarkers. This report contains market size and forecasts of Genomics Biomarkers in global, including the following market information:
Global Genomics Biomarkers Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Genomics Biomarkers market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The increasing instances of low-cost clinical trials in developing countries will drive the growth prospects for the global genomics biomarkers market until the end of 2021. This globalization of clinical trials has been credited to numerous components that include organized trials, the willingness of members facilitating the enrollment, accessibility of qualified local investigators, enhanced opportunities in various Tier 2 and Tier 3 countries, and lower expenses of clinical trials in developing nations. Some of the other factors responsible for the increasing preference for disease-based genomic biomarkers such as cancer biomarkers testing includes the faster and precise analysis of diseases and potential lowering in volume and time involved in clinical trials.
We surveyed the Genomics Biomarkers companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Genomics Biomarkers Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Genomics Biomarkers Market Segment Percentages, by Type, 2022 (%)
Oncology
Cardiovascular Diseases
Neurological Diseases
Global Genomics Biomarkers Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Genomics Biomarkers Market Segment Percentages, by Application, 2022 (%)
Diagnostic and Research Laboratories
Hospitals
Global Genomics Biomarkers Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Genomics Biomarkers Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Genomics Biomarkers revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Genomics Biomarkers revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche Diagnostics
Myriad Genetics
QIAGEN
Thermo Fisher Scientific
Bio-Rad Laboratories
Outline of Major Chapters:
Chapter 1: Introduces the definition of Genomics Biomarkers, market overview.
Chapter 2: Global Genomics Biomarkers market size in revenue.
Chapter 3: Detailed analysis of Genomics Biomarkers company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Genomics Biomarkers in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
